{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:50:39Z","timestamp":1790898639632,"version":"4.1.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Down syndrome (DS) is the most frequent autosomal aneuploidy, and it arises due to an extra copy of human chromosome 21. Individuals with trisomy 21 (T21) exhibit an increased predisposition towards a wide number of developmental and physiological alterations, often referred to as DS co-occurring conditions, including congenital heart disease, leukemia, intellectual disability, neurodegenerative disorders or autoimmune diseases, among many others. The overexpression of several genes encoded on chromosome 21 have been linked to many of such T21-associated disorders, but we are still very far from grasping a full picture of the contributions and interconnections of such genes in the pathophysiology of DS. DYRK1A is a versatile and ubiquitous kinase encoded on human chromosome 21, and as such, its activity has been linked to many alterations that characterize DS. Although most of the attention has been focused on DYRK1A\u2019s roles in neural development, function and degeneration, accumulating reports are expanding the scope towards other tissues and conditions where this kinase also performs critical functions, such as the cardiovascular system, diabetes, inflammation and immune homeostasis. Here, we present a detailed review of the literature summarizing all the information linking DYRK1A to blood and immune function, as well as leukemia, inflammation and viral infections, with a special focus on their potential associations to T21. This article synthesizes evidence that supports several novel hypotheses on previously unsuspected roles for DYRK1A in specific DS alterations, opening new pathways for the research community to explore and therefore, contributing to future innovative diagnostic or therapeutic interventions. This article will hopefully inspire and guide the advancement of our knowledge leading to much needed treatments for individuals with Down syndrome, but also for the general population.<\/jats:p>","DOI":"10.3389\/fcell.2025.1587089","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:44:10Z","timestamp":1748583850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Esteban J.","family":"Rozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin D.","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1277537","DOI":"10.3389\/fcell.2023.1277537","article-title":"Insights from the protein interaction Universe of the multifunctional \u201cGoldilocks\u201d kinase DYRK1A","volume":"11","author":"Ananthapadmanabhan","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B4","doi-asserted-by":"publisher","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3390\/genes12111833","article-title":"Dyrk1a from gene function in development and physiology to dosage correction across life span in down syndrome","volume":"12","author":"Atas-Ozcan","year":"2021","journal-title":"Genes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1182\/blood-2022-162782","article-title":"Pharmacologic inhibition of DYRK1A results in hyperactivation and hyperphosphorylation of MYC and ERK rendering kmt2a-R ALL cells sensitive to BCL2 inhibition","volume":"140","author":"Ayyadevara","year":"2022","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41375-025-02575-w","article-title":"DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition: acute lymphoblastic leukemia","volume":"39","author":"Ayyadevara","year":"2025","journal-title":"Leukemia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3324\/haematol.2023.283225","article-title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","volume":"108","author":"Baruchel","year":"2023","journal-title":"Haematologica"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e135937","DOI":"10.1172\/JCI135937","article-title":"DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3","volume":"131","author":"Bhansali","year":"2021","journal-title":"J. Clin. Investigation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e17190","DOI":"10.1371\/journal.pone.0017190","article-title":"Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages","volume":"6","author":"Bol","year":"2011","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0144229","DOI":"10.1371\/journal.pone.0144229","article-title":"DYRK1A controls HIV-1 replication at a transcriptional level in an NFAT dependent manner","volume":"10","author":"Booiman","year":"2015","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","article-title":"Acute lymphoblastic leukemia in children with Down syndrome: A retrospective analysis from the Ponte di Legno study group","volume":"123","author":"Buitenkamp","year":"2014","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3324\/haematol.2023.284271","article-title":"Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia","volume":"109","author":"Carey-Smith","year":"2024","journal-title":"Haematologica"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0254184","DOI":"10.1371\/journal.pone.0254184","article-title":"NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia","volume":"16","author":"Catherinet","year":"2021","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1021\/acs.jmedchem.6b01083","article-title":"An unusual binding model of the methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases","volume":"59","author":"Chaikuad","year":"2016","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/ijc.22573","article-title":"Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis","volume":"120","author":"Chang","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41375-024-02151-8","article-title":"Inherent genome instability underlies trisomy 21-associated myeloid malignancies","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/jir.12572","article-title":"Hospitalisation of adults with Down syndrome: lesson from a 10-year experience from a community hospital","volume":"63","author":"Chenbhanich","year":"2019","journal-title":"J. Intellect. Disabil. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"dmm037044","DOI":"10.1242\/dmm.037044","article-title":"Vascular defects of DYRK1A knockouts are ameliorated by modulating calcium signaling in zebrafish","volume":"12","author":"Cho","year":"2019","journal-title":"DMM Dis. Models Mech."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/JIR.S280953","article-title":"Interferon-driven immune dysregulation in down syndrome: a review of the evidence","volume":"14","author":"Chung","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.7326\/M20-4986","article-title":"COVID-19 mortality risk in down syndrome: results from a cohort study of 8 million adults","volume":"174","author":"Clift","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1128\/JVI.00786-13","article-title":"Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation","volume":"87","author":"Cohen","year":"2013","journal-title":"J. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10694","DOI":"10.1021\/acs.jmedchem.3c00884","article-title":"Leucettinibs, a class of DYRK\/CLK kinase inhibitors inspired by the marine sponge natural product leucettamine B","volume":"66","author":"Deau","year":"2023","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.3390\/ijms23169355","article-title":"The omnipresence of DYRK1A in human diseases","volume":"23","author":"Deboever","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.joca.2019.05.006","article-title":"Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment","volume":"27","author":"Deshmukh","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41598-021-81451-w","article-title":"Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19","volume":"11","author":"De Toma","year":"2021","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fimmu.2020.00840","article-title":"Immune defect in adults with down syndrome: insights into a complex issue","volume":"11","author":"Dieudonn\u00e9","year":"2020","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/NEN.0b013e31827733c8","article-title":"Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients","volume":"71","author":"Dowjat","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3233\/JAD-190475","article-title":"Abnormalities of dyrk1a-cytoskeleton complexes in the blood cells as potential biomarkers of Alzheimer\u2019s disease","volume":"72","author":"Dowjat","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/v16060918","article-title":"Human cytomegalovirus dysregulates cellular dual-specificity tyrosine phosphorylation-regulated kinases and sonic hedgehog pathway proteins in neural astrocyte and placental models","volume":"16","author":"Egilmezer","year":"2024","journal-title":"Viruses"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e154839","DOI":"10.1172\/JCI154839","article-title":"Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes","volume":"132","author":"Elagib","year":"2022","journal-title":"J. Clin. Investigation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","article-title":"Down syndrome and COVID-19: a perfect storm?","volume":"1","author":"Espinosa","year":"2020","journal-title":"Cell Rep. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3389\/fimmu.2018.02683","article-title":"Dysregulated miR-155 and miR-125b are related to impaired B-cell responses in down syndrome","volume":"9","author":"Farroni","year":"2018","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1242\/jeb.112.1.65","article-title":"Neurogenetics and behaviour in insects","volume":"112","author":"Fischbach","year":"1984","journal-title":"J. Exp. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.17294\/2330-0698.1876","article-title":"Prevalence of infectious diseases among 6078 individuals with down syndrome in the United States","volume":"9","author":"Fitzpatrick","year":"2022","journal-title":"J. Patient Cent. Res. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0123923","DOI":"10.1128\/jvi.01239-23","article-title":"DYRK1A is a multifunctional host factor that regulates coronavirus replication in a kinase-independent manner","volume":"98","author":"Fu","year":"2024","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"eadg6218","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith","year":"2023","journal-title":"Sci. Adv."},{"key":"B39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10875-024-01725-6","article-title":"Dysregulation of the immune system in a natural history study of 1299 individuals with down syndrome","volume":"44","author":"Gansa","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1182\/blood.2022019094","article-title":"The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21","volume":"142","author":"Gao","year":"2023","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood.2022017619","article-title":"RUNX1 isoform disequilibrium promotes the development of trisomy 21\u2013associated myeloid leukemia","volume":"141","author":"Gialesaki","year":"2023","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/imm.13538","article-title":"Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients","volume":"167","author":"Giri","year":"2022","journal-title":"Immunology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"111174","DOI":"10.1016\/j.intimp.2023.111174","article-title":"Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells\u2019 suppressive capacity in generalized vitiligo","volume":"125","author":"Giri","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"28241","DOI":"10.1038\/srep28241","article-title":"The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2","volume":"6","author":"Glenewinkel","year":"2016","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/biomedicines11030821","article-title":"Updates in KMT2A gene rearrangement in pediatric acute lymphoblastic leukemia","volume":"11","author":"G\u00f3recki","year":"2023","journal-title":"Biomedicines"},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fimmu.2020.00541","article-title":"NF-\u03baB1 regulates immune environment and outcome of notch-dependent T-cell acute lymphoblastic leukemia","volume":"11","author":"Grazioli","year":"2020","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-022-01013-1","article-title":"Genome-scale CRISPR screens identify host factors that promote human coronavirus infection","volume":"14","author":"Grodzki","year":"2022","journal-title":"Genome Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tice.2018.10.002","article-title":"Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway","volume":"55","author":"Guo","year":"2018","journal-title":"Tissue Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"115046","DOI":"10.1016\/j.bcp.2022.115046","article-title":"The paradox of Myeloid Leukemia associated with Down syndrome","volume":"201","author":"Gupte","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.placenta.2018.10.002","article-title":"Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication","author":"Hamilton","year":"2018","journal-title":"Placenta"},{"key":"B51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5603\/fhc.96703","article-title":"miRNA-192-5p targets Dyrk1a to attenuate cerebral injury in MCAO mice by suppressing neuronal apoptosis and neuroinflammation","volume":"61","author":"He","year":"2024","journal-title":"Folia Histochem Cytobiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s42003-024-05986-0","article-title":"MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A\/STAT3 signaling pathway to promote wound healing in diabetes","volume":"7","author":"Hu","year":"2024","journal-title":"Commun. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.eclinm.2021.100769","article-title":"Medical vulnerability of individuals with Down syndrome to severe COVID-19\u2013data from the Trisomy 21 Research Society and the UK ISARIC4C survey","volume":"33","author":"H\u00fcls","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pbc.24420","article-title":"Children\u2019s oncology Group\u2019s 2013 blueprint for research: acute lymphoblastic leukemia","volume":"60","author":"Hunger","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.antiviral.2017.04.003","article-title":"Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity","volume":"143","author":"Hutterer","year":"2017","journal-title":"Antivir. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12017-021-08651-5","article-title":"Specific susceptibility to COVID-19 in adults with down syndrome","volume":"23","author":"Illouz","year":"2021","journal-title":"Neuromolecular Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"686","DOI":"10.15252\/embr.201338356","article-title":"DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1\u2010mediated transcriptional repression","volume":"15","author":"Jang","year":"2014","journal-title":"EMBO Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-021-03929-x","article-title":"Blood and immune development in human fetal bone marrow and Down syndrome","volume":"598","author":"Jardine","year":"2021","journal-title":"Nature"},{"key":"B61","unstructured":"LYMPHOID NEOPLASIA Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia\n          \n          \n            \n              Jin\n              Q.\n            \n            \n              Harris\n              E.\n            \n            \n              Myers\n              J. A.\n            \n            \n              Mehmood\n              R.\n            \n            \n              Cotton\n              A.\n            \n            \n              Shirnekhi\n              H. K.\n            \n          \n          \n          2024"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s10753-022-01699-w","article-title":"Inhibition of Dyrk1A attenuates LPS-induced neuroinflammation via the TLR4\/NF-\u03baB P65 signaling pathway","volume":"45","author":"Ju","year":"2022","journal-title":"Inflammation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"40401","DOI":"10.1074\/jbc.M111.253971","article-title":"Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation","volume":"286","author":"Jung","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B64","first-page":"127","article-title":"Understanding the multifaceted role of human down syndrome kinase DYRK1A","volume-title":"Advances in protein chemistry and structural biology","author":"Kay","year":"2016"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e05920","DOI":"10.7554\/eLife.05920","article-title":"The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells","volume":"4","author":"Khor","year":"2015","journal-title":"Elife"},{"key":"B66","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.jtauto.2022.100185","article-title":"FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis","volume":"6","author":"Kim","year":"2023","journal-title":"J. Transl. Autoimmun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e01583","DOI":"10.1128\/JVI.01583-19","article-title":"The dual-specificity kinase DYRK1A modulates the levels of cyclin L2 to control HIV replication in macrophages","volume":"94","author":"Kisaka","year":"2020","journal-title":"J. Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/JVI.02119-09","article-title":"Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1\/K2 transcription factors","volume":"84","author":"Komorek","year":"2010","journal-title":"J. Virol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.chom.2014.11.009","article-title":"Cyclin L2 is a critical HIV dependency factor in macrophages that controls samhd1 abundance","volume":"17","author":"Kyei","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/apa.15153","article-title":"Multiorgan involvement and management in children with Down syndrome","volume":"109","author":"Lagan","year":"2020","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00018-020-03626-4","article-title":"DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis","volume":"78","author":"Laham","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"eabi4888","DOI":"10.1126\/scitranslmed.abi4888","article-title":"Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity","volume":"14","author":"Lambert","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2297642","DOI":"10.1080\/10641963.2023.2297642","article-title":"Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3\/Pim-1\/NFAT pathway","volume":"46","author":"Lan","year":"2024","journal-title":"Clin. Exp. Hypertens."},{"key":"B74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10020-022-00492-7","article-title":"RCAN1-mediated calcineurin inhibition as a target for cancer therapy","volume":"28","author":"Lao","year":"2022","journal-title":"Mol. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s43018-023-00518-x","article-title":"Author Correction: an inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2023","journal-title":"Nat. Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s12035-018-1113-x","article-title":"LPS-induced inflammation abolishes the effect of DYRK1A on IkB stability in the brain of mice","volume":"56","author":"Latour","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-19-3519","article-title":"Constitutive activation of RAS\/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in down syndrome b-cell leukemia","volume":"26","author":"Laurent","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/leu.2016.164","article-title":"The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome","volume":"30","author":"Lee","year":"2016","journal-title":"Leukemia"},{"key":"B79","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1182\/blood.2021011247","article-title":"DYRK1a mediates BAFF-induced noncanonical NF-\u03baB activation to promote autoimmunity and B-cell leukemogenesis","volume":"138","author":"Li","year":"2021","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1182\/blood.2023019765","article-title":"Genomic landscape of Down syndrome\u2013associated acute lymphoblastic leukemia","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.biocel.2008.04.003","article-title":"DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues","volume":"40","author":"Liang","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e98853","DOI":"10.1371\/journal.pone.0098853","article-title":"Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"114062","DOI":"10.1016\/j.ejmech.2021.114062","article-title":"DYRK1A inhibitors for disease therapy: current status and perspectives","volume":"229","author":"Liu","year":"","journal-title":"Eur. J. Med. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41419-022-05517-x","article-title":"Embryonic organizer formation disorder leads to multiorgan dysplasia in Down syndrome","volume":"13","author":"Liu","year":"","journal-title":"Cell Death Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1021\/acs.jmedchem.9b01624","article-title":"Selective DYRK1A inhibitor for the treatment of type 1 diabetes: discovery of 6-azaindole derivative GNF2133","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s10753-023-01813-6","article-title":"Deletion of DYRK1A accelerates osteoarthritis progression through suppression of EGFR-ERK signaling","volume":"46","author":"Liu","year":"2023","journal-title":"Inflammation"},{"key":"B89","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1172\/JCI60455","article-title":"Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome","volume":"122","author":"Malinge","year":"2012","journal-title":"J. Clin. Invest"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","article-title":"Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in down syndrome","volume":"113","author":"Malinge","year":"2009","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","article-title":"Individuals with Down syndrome hospitalized with COVID-19 have more severe disease","volume":"23","author":"Malle","year":"2021","journal-title":"Genet. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.immuni.2022.09.007","article-title":"Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome","volume":"55","author":"Malle","year":"2022","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c+ B cells","volume":"615","author":"Malle","year":"2023","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2009-07-235291","article-title":"Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children\u2019s Oncology Group","volume":"116","author":"Maloney","year":"2010","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"vlae005","DOI":"10.1093\/immhor\/vlae005","article-title":"Defining a novel DYRK1A-gp130\/IL-6R-pSTAT axis that regulates Th17 differentiation","volume":"9","author":"Malueg","year":"2025","journal-title":"Immunohorizons"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0034724","DOI":"10.1128\/jvi.00347-24","article-title":"The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection","volume":"98","author":"Mao","year":"2024","journal-title":"J. Virol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","article-title":"Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons","volume":"22","author":"Martinez De Lagran","year":"2012","journal-title":"Cereb. Cortex"},{"key":"B98","doi-asserted-by":"publisher","first-page":"20406207241257901","DOI":"10.1177\/20406207241257901","article-title":"Down syndrome-associated leukaemias: current evidence and challenges","volume":"15","author":"Mason","year":"2024","journal-title":"Ther. Adv. Hematol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3978\/j.issn.2224-4336.2015.03.03","article-title":"Down syndrome and leukemia: insights into leukemogenesis and translational targets","volume":"4","author":"Mateos","year":"2015","journal-title":"Transl. Pediatr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1391564","DOI":"10.3389\/fnmol.2024.1391564","article-title":"Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions","volume":"17","author":"Murphy","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1462893","DOI":"10.3389\/fnins.2024.1462893","article-title":"Skeletal health in DYRK1A syndrome","volume":"18","author":"Otte","year":"2024","journal-title":"Front. Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5607\/en.2013.22.4.244","article-title":"New perspectives of Dyrk1A role in neurogenesis and neuropathologic features of down syndrome","volume":"22","author":"Park","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e0311655","DOI":"10.1371\/journal.pone.0311655","article-title":"The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA","volume":"19","author":"Pastor","year":"2024","journal-title":"PLoS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2012.04610.x","article-title":"Down syndrome, autoimmunity and T regulatory cells","volume":"169","author":"Pellegrini","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/hmg\/ddw116","article-title":"Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype","volume":"25","author":"Pelleri","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e797","DOI":"10.1002\/mgg3.797","article-title":"Partial trisomy 21 map: ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21","volume":"7","author":"Pelleri","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/jcmm.17817","article-title":"Over-expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice","volume":"27","author":"Postic","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5021\/ad.22.126","article-title":"MicroRNA-1246 inhibits NFATc1 phosphorylation and regulates T helper 17 cell activation in the pathogenesis of severe Alopecia Areata","volume":"35","author":"Qi","year":"2023","journal-title":"Ann. Dermatol."},{"key":"B109","article-title":"Evaluating MERS-CoV entry pathways","volume-title":"Methods in molecular biology","author":"Qing","year":"2020"},{"key":"B110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/imr.13296","article-title":"The immune system in Down Syndrome: autoimmunity and severe infections","volume":"322","author":"Ramba","year":"2024","journal-title":"Immunol. Rev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41388-022-02245-6","article-title":"The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target","volume":"41","author":"Rammohan","year":"2022","journal-title":"Oncogene"},{"key":"B113","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bjh.13096","article-title":"Haematopoietic development and leukaemia in Down syndrome","volume":"167","author":"Roberts","year":"2014","journal-title":"Br. J. Haematol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","article-title":"Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution","volume":"55","author":"Rodriguez-Meira","year":"2023","journal-title":"Nat. Genet."},{"key":"B115","doi-asserted-by":"publisher","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40246-023-00531-2","article-title":"RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome","volume":"17","author":"Rozen","year":"2023","journal-title":"Hum. Genomics"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.celrep.2018.04.008","article-title":"DYRK1A kinase positively regulates angiogenic responses in endothelial cells","volume":"23","author":"Rozen","year":"2018","journal-title":"Cell Rep."},{"key":"B118","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"key":"B119","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ajmg.a.61924","article-title":"Pneumonia and respiratory infections in Down syndrome: a scoping review of the literature","volume":"185","author":"Santoro","year":"2021","journal-title":"Am. J. Med. Genet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/database\/bau009","article-title":"Analysis of expression on human chromosome 21, ALE-HSA21: a pilot integrated web resource","volume":"2014","author":"Scarpato","year":"2014","journal-title":"Database"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e27459","DOI":"10.1097\/MD.0000000000027459","article-title":"Outcomes of patients with Down syndrome and acute leukemia: a retrospective observational study","volume":"100","author":"Schmidt","year":"2021","journal-title":"Med. (United States)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"e172851","DOI":"10.1172\/jci.insight.172851","article-title":"Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis","volume":"8","author":"Sit","year":"2023","journal-title":"JCI Insight"},{"key":"B123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neulet.2013.08.066","article-title":"Dyrk1A-mediated phosphorylation of RCAN1 promotes the formation of insoluble RCAN1 aggregates","volume":"554","author":"Song","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41467-023-37205-5","article-title":"B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation","volume":"14","author":"Stoler-Barak","year":"2023","journal-title":"Nat. Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e3002097","DOI":"10.1371\/journal.pbio.3002097","article-title":"DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner","volume":"21","author":"Strine","year":"2023","journal-title":"PLoS Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/mgg3.334","article-title":"Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits","volume":"5","author":"Stringer","year":"2017","journal-title":"Mol. Genet. Genomic Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/hmg\/ddad162","article-title":"Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A\/PPARG\/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertension","volume":"33","author":"Suginobe","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"B128","doi-asserted-by":"publisher","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/pbc.25624","article-title":"Transient myeloproliferative disorder with partial trisomy 21","volume":"62","author":"Takahashi","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"B130","unstructured":"DYRK1A kinase triplication is the major cause of Otitis Media in Down Syndrome\n          \n          \n            \n              Tateossian\n              H.\n            \n            \n              Southern\n              A.\n            \n            \n              Vikhe\n              P.\n            \n            \n              Lana-Elola\n              E.\n            \n            \n              Watson-Scales\n              S.\n            \n            \n              Gibbins\n              D.\n            \n          \n          \n          2025"},{"key":"B131","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.20150002","article-title":"DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3","volume":"212","author":"Thompson","year":"2015","journal-title":"J. Exp. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer."},{"key":"B133","doi-asserted-by":"publisher","first-page":"108407","DOI":"10.1016\/j.celrep.2020.108407","article-title":"JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndrome","volume":"33","author":"Tuttle","year":"2020","journal-title":"Cell Rep."},{"key":"B134","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.imlet.2019.08.003","article-title":"Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency","volume":"214","author":"Valencic","year":"2019","journal-title":"Immunol. Lett."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","article-title":"Defective B-cell memory in patients with Down syndrome","volume":"134","author":"Verstegen","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"104605","DOI":"10.1016\/j.jbc.2023.104605","article-title":"A bivalent \u03b2-carboline derivative inhibits macropinocytosis-dependent entry of pseudorabies virus by targeting the kinase DYRK1A","volume":"299","author":"Wang","year":"2023","journal-title":"J. Biol. Chem."},{"key":"B137","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","article-title":"Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in down syndrome","volume":"29","author":"Waugh","year":"2019","journal-title":"Cell Rep."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41588-023-01399-7","article-title":"Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model","volume":"55","author":"Waugh","year":"2023","journal-title":"Nat. Genet."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1182\/blood-2008-01-134122","article-title":"PEBP2-beta\/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis","volume":"112","author":"Wee","year":"2008","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.2019002639","article-title":"Feed-forward regulatory loop driven by IRF4 and NF-\u03baB in adult T-cell leukemia\/lymphoma","volume":"135","author":"Wong","year":"2020","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","first-page":"115521","DOI":"10.1016\/j.bcp.2023.115521","article-title":"Function and inhibition of DYRK1A: emerging roles of treating multiple human diseases","volume":"212","author":"Yang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ygyno.2015.06.015","article-title":"Down-regulation of MIR-1246 in cervical cancer tissues and its clinical significance","volume":"138","author":"Yang","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/art.41315","article-title":"Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment of knee osteoarthritis: a Phase II randomized trial","volume":"72","author":"Yazici","year":"2020","journal-title":"Arthritis Rheumatology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.joca.2021.02.004","article-title":"A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2\/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis","volume":"29","author":"Yazici","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1021\/acs.jmedchem.6b01840","article-title":"Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in glioblastoma","volume":"60","author":"Zhou","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1587089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:44:12Z","timestamp":1748583852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1587089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":147,"alternative-id":["10.3389\/fcell.2025.1587089"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1587089","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"article-number":"1587089"}}